Thr200
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr200  -  NANOG (human)

Site Information
LPMWSNQtWNNSTWS   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 28070707

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
'stem, prostate cancer' ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKCE (human) ( 2 )
Kinases, in vitro:
PKCE (human) ( 2 )
Treatments:
ibuprofen ( 1 ) , MK-591 ( 1 )

References 

1

Sarveswaran S, Varma N, Morisetty S, Ghosh J (2016) Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase. Oncotarget
27880719   Curated Info

2

Xie X, et al. (2014) Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene 33, 2040-52
23708658   Curated Info